Left ventricular hypertrophy and insulin resistance in adults from an urban community in the Gambia: Cross-sectional study

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Nkum, Bernard Cudjoe ^a   Micah, Frank Botsi ^a   Ankrah, Theophilus C ^a   Nyan, Ousman ^b  

^a KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

^b Royal Victoria Teaching Hospital Gambia   (Gambia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; GAMBIA; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; INSULIN RESISTANCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; QUESTIONNAIRE; URBAN POPULATION; DEMOGRAPHY; ELECTROCARDIOGRAPHY; GLUCOSE TOLERANCE TEST; HYPERTROPHY, LEFT VENTRICULAR; MIDDLE AGED; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; GAMBIA; GLUCOSE TOLERANCE TEST; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; INSULIN RESISTANCE; MALE; MIDDLE AGED; RESIDENCE CHARACTERISTICS; URBAN POPULATION;

EID: 84899456277     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093606     Document Type: Article

References (38)

1. Alberti KG, Zimmet P, Shaw J (2006) Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 23(5):469-80.
2. Kahan T (1998) The importance of left ventricular hypertrophy in human hypertension. J Hypertens Suppl. 16(7):S23-9.
3. Agabiti-Rosei E, Muiesan ML, Salvetti M (2006) Evaluation of subclinical target organ damage for risk assessment and treatment in the hypertensive patients: left ventricular hypertrophy. J Am Soc Nephrol. 17(4 Suppl 2):S104-8.
4. Ruilope LM, Schmieder RE (2008) Left ventricular hypertrophy and clinical outcomes in hypertensive patients. Am J Hypertens. 21(5):500-8. Epub 2008 Mar 13.
5. Sasson Z, Rasool Y, Bhesania T, Rasooly I (1993) Insulin resistance is an important determinant of left ventricular mass in the obese. Circulation. 88(4 Pt1):1431-6. (Pubitemid 23296888)
6. Lind L, Andersson PE, Andrén B, Hänni A, Lithell HO (1995) Left ventricular hypertrophy in hypertension is associated with the insulin resistance metabolic syndrome. J Hypertens. 13(4):433-8.
7. Costa CH, Batista MC, Moises VA, Kohlmann NB, Ribeiro AB, et al. (1995) Serum insulin levels, 24-hour blood pressure profile, and left ventricular mass in nonobese hypertensive patients. Hypertension. 26(6 Pt 2):1085-8.
8. Galvan AQ, Galetta F, Natali A, Muscelli E, Sironi AM, et al. (2000) Insulin resistance and hyperinsulinemia: No independent relation to left ventricular mass in humans. Circulation. 102(18):2233-8.
9. Expert Committee on Arterial Hypertension and Ischaemic Heart Disease. Arterial hypertension and ischaemic heart disease: preventive aspects; Report of an expert committee. Wld Hlth Org. techn. Rep. Ser. No. 231. 1962; 28.
10. Hammond IW, Devereux RB, Alderman MH, Lutas EM, Spitzer MC, et al. (1986) The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension. J Am Coll Cardiol. 7: 639-650. (Pubitemid 16164393)
11. Mayet J, Shahi M, Foale RA, Poulter NR, Sever PS, et al. (1994) Racial differences in cardiac structure and function in essential hypertension. Br Med J. 308:1011-1014. (Pubitemid 24115035)
12. Attah EB, Falase AO (1977) Large flabby hearts in hypertension. Am Heart J. 94: 189-195.
13. Rydén L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, et al. (2007) Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC); European Association for the Study of Diabetes (EASD). Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J. 28(1):88-136. (Pubitemid 46137814)
14. (2007) Compendium of European Society of Cardiology Guidelines 2007. Pp 19.
15. Nkum BC, Nyan O, Corrah T, Ankrah TC, Allen S, et al. (2009) Resting electrocardiographic and echocardiographic findings in an urban community in the Gambia. Journal of Science and Technology. 29:130-140.
16. Okada K, Hirano T, Ran J, Adachi M (2004) Olmesartan medoxomil, an angiotensin II receptor blocker ameliorates insulin resistance and decreases triglyceride production in fructose-fed rats. Hypertens Res. 27(4):293-9. (Pubitemid 38594401)
17. Nickenig G, Röling J, Strehlow K, Schnabel P, Böhm M (1998) Insulin induces upregulation of vascular AT1 receptor gene expression by posttranscriptional mechanisms. Circulation. 98(22):2453-60. (Pubitemid 28549791)
18. Daemen MJ, Lombardi DM, Bosman FT, Schwartz SM (1991) Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res. 68(2):450-6.
19. Homcy CJ (1998) Signaling hypertrophy: how many switches, how many wires. Circulation. 97(19):1890-2.
20. Whaley-Connell A, Govindarajan G, Habibi J, Hayden MR, Cooper SA, et al. (2007) Angiotensin II-mediated oxidative stress promotes myocardial tissue remodeling in the transgenic (mRen2) 27 Ren2 rat. Am J Physiol Endocrinol Metab. 293(1):E355-63. Epub 2007 Apr 17.
21. Rocchini AP, Katch V, Kveselis D, Moorehead C, Martin M, et al. (1989) Insulin and renal sodium retention in obese adolescents. Hypertension. 14(4):367-74. (Pubitemid 19256537)
22. Poornima IG, Parikh P, Shannon RP (2006) Diabetic cardiomyopathy: the search for a unifying hypothesis. Circ Res. 98(5):596-605.
23. Scherrer U, Sartori C (1997) Insulin as a vascular and sympathoexcitatory hormone: implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity. Circulation. 96(11):4104-13.
24. Ito H, Hiroe M, Hirata Y, Tsujino M, Adachi S, et al. (1993) Insulin-like growth factor-I induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes. Circulation. 87(5):1715-21. (Pubitemid 23133116)
25. Hsueh WA, Law RE (1999) Insulin signaling in the arterial wall. Am J Cardiol. 84(1A):21J-24J. (Pubitemid 29334856)
26. Ferrannini E, Haffner SM, Mitchell BD, Stern MP (1991) Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia. 34(6):416-22.
27. Grundy SM (1998) Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome. Am J Cardiol. 81(4A):18B-25B.
28. Urbina EM, Gidding SS, Bao W, Elkasabany A, Berenson GS (1999) Association of fasting blood sugar level, insulin level, and obesity with left ventricular mass in healthy children and adolescents: The Bogalusa Heart Study. Am Heart J. 138(1 Pt 1):122-7. (Pubitemid 29331131)
29. Sharp SD, Williams RR (1992) Fasting insulin and left ventricular mass in hypertensives and normotensive controls. Cardiology. 81(4-5):207-12. (Pubitemid 23113872)
30. Verdecchia P, Reboldi G, Schillaci G, Borgioni C, Ciucci A, et al. (1999) Circulating insulin and insulin growth factor-1 are independent determinants of left ventricular mass and geometry in essential hypertension. Circulation. 100(17):1802-7. (Pubitemid 29498387)
31. Rutter MK, Parise H, Benjamin EJ, Levy D, Larson MG, et al. (2003) Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study. Circulation. 107(3):448-54. (Pubitemid 36158048)
32. Ilercil A, Devereux RB, Roman MJ, Paranicas M, O'Grady MJ, et al. (2002) Associations of insulin levels with left ventricular structure and function in American Indians: the strong heart study. Diabetes. 51(5):1543-7. (Pubitemid 34826623)
33. Rheeder P, Stolk RP, Mosterd A, Pols HA, Hofman A, et al. (1999) Insulin resistance syndrome and left ventricular mass in an elderly population (The Rotterdam Study). Am J Cardiol. 84(2):233-6, A9.
34. Malmqvist K, Isaksson H, Ostergren J, Kahan T (2001) Left ventricular mass is not related to insulin sensitivity in never-treated primary hypertension. J Hypertens. 19(2):311-7. (Pubitemid 32116283)
35. Barud W, Makaruk B, Myśliński W, Palusiński R, Hanzlik J (2004) Hypertension, and not sex hormones or insulin resistance affects left ventricular mass in aging men. Ann Univ Mariae Curie Sklodowska [Med]. 59(1):232-6.
36. Top C, Sahan B, Onde ME (2007) The relationship between left ventricular mass index and insulin sensitivity, postprandial glycaemia, and fasting serum triglyceride and adiponection levels in patients with type 2 diabetes. J Int Med Res. 35(6):909-16. (Pubitemid 350238425)
37. Ebinç H, Ebinç FA, Ozkurt ZN, Doǧru T, Yilmaz M (2006) Relationship of left ventricular mass to insulin sensitivity and body mass index in healthy individuals. Acta Cardiol. 61(4):398-405. (Pubitemid 44342423)
38. Sherif K, Barrett M, Kushner H, Falkner B (2000) The association of left ventricular mass with cardiovascular risk factors in African American women. Am J Med Sci. 320(1):13-7. (Pubitemid 30471285)